Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $22.06M | $17.75M | $14.77M | $18.46M |
| Net Income | $6.17M | $4.96M | $1.65M | $2.98M |
| EPS Diluted | $0.40 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.33 |
| $0.11 |
| $0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
